How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Micropumps for Medical Market
- By Pump Technology: Piezoelectric Micropumps, Electrohydrodynamic Micropumps, Thermal Bubble Micropumps, Electrostatic Micropumps, Magnetostrictive Micropumps
- By Application: Drug Delivery Systems, Dialysis Machines, Infusion Pumps, Respiratory Devices, Laboratory Automation
- By Fluid Type: Blood, Saline Solution, Medication Liquids, Biological Samples, Gases
- By Drive Mechanism: Mechanical Actuation, Electromagnetic Actuation, Electrostatic Actuation, Thermal Actuation
- By End-User: Hospitals, Home Healthcare, Research Laboratories, Pharmaceutical Companies
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Piezoelectric Micropumps leads By Pump Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Micropumps for Medical Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Pump Technology 5
Application 5
Fluid Type 5
Drive Mechanism 4
End-User 4
Companies profiled
Tecan Group Ltd.
Harvard Apparatus (Harvard Bioscience
Inc.)
Bartels Mikrotechnik GmbH
Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.)
Micrel Medical Devices
NResearch Inc.
Debiotech SA
Stevanato Group
Fluigent
CETONI GmbH
Instech Laboratories Inc.
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Tecan Group Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Harvard Apparatus (Harvard Bioscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Bartels Mikrotechnik GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Micrel Medical Devices
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NResearch Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Debiotech SA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Stevanato Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Fluigent
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →CETONI GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Instech Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Micropump
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Inc. (a unit of IDEX Corporation)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sensirion AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Bio-Chem Fluidics Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →ThalesNano
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,339M by 2033 · 3.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Piezoelectric Micropumps52.8
- Electrohydrodynamic Micropumps10.4
- Thermal Bubble Micropumps8.9
- Electrostatic Micropumps7.7
- Magnetostrictive Micropumps20.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$333.8M → $419.4M · 2.9%
Europe$232.6M → $297.9M · 3.1%
Asia Pacific$212.4M → $265.2M · 2.8%
Latin America$131.5M → $180.6M · 4.0%
Middle East and Africa$101.1M → $141.0M · 4.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.512026
3.532027
3.532028
3.552029
3.562030
3.592031
3.592032
3.602033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Tecan Group Ltd.18.9
- Harvard Apparatus (Harvard Bioscience20.1
- Inc.)7.3
- Bartels Mikrotechnik GmbH6.3
- Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.)10.6
- Micrel Medical Devices8.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Pump Technology22.7%
Application17.9%
Fluid Type19.4%
Drive Mechanism19.5%
End-User20.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe22.8
- Asia Pacific20.3
- Latin America13.9
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Tecan Group Ltd. | 97 | 91 | 89 | 93 | 90 | 87 | 91 |
| Harvard Apparatus (Harvard Bioscience | 91 | 85 | 70 | 87 | 85 | 68 | 81 |
| Inc.) | 63 | 69 | 63 | 84 | 83 | 73 | 73 |
| Bartels Mikrotechnik GmbH | 74 | 75 | 65 | 59 | 78 | 68 | 70 |
| Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.) | 54 | 62 | 58 | 64 | 63 | 67 | 61 |
| Micrel Medical Devices | 64 | 58 | 70 | 47 | 58 | 52 | 58 |
| NResearch Inc. | 43 | 63 | 58 | 64 | 63 | 54 | 58 |
| Debiotech SA | 58 | 41 | 55 | 45 | 49 | 37 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Tecan Group Ltd.
- Harvard Apparatus (Harvard Bioscience
- Inc.)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Tecan Group Ltd. | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Harvard Apparatus (Harvard Bioscience | ✓ | ✓ | − | ◐ | ✓ | − |
| Inc.) | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Bartels Mikrotechnik GmbH | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.) | ◐ | − | ◐ | − | − | − |
| Micrel Medical Devices | − | ◐ | ◐ | − | ◐ | ◐ |
| NResearch Inc. | ◐ | − | ◐ | ◐ | − | ◐ |
| Debiotech SA | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Tecan Group Ltd.91
2Harvard Apparatus (Harvard Bioscience81
3Inc.)73
4Bartels Mikrotechnik GmbH70
5Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.)61
6Micrel Medical Devices58
7NResearch Inc.58
8Debiotech SA48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Tecan Group Ltd.Harvard Apparatus (Harvard Bioscience
Challenger2
Strong scale, closing on the leaders.
Inc.)Bartels Mikrotechnik GmbH
Contender3
Focused players with pockets of strength.
Dolomite Microfluidics (a division of Blacktrace Holdings Ltd.)Micrel Medical DevicesNResearch Inc.
Niche1
Specialists in a single segment or region.
Debiotech SA
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Pump Technology in North America, then scale across Micropumps for Medical Market — a $637M beachhead inside a $8.78B market.
Beachhead (SOM)$637Mobtainable near-term
Serviceable (SAM)$3.47Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Piezoelectric Micropumps
Best fit — highest urgency & budget in Pump Technology.
Economic buyer75 fit
Electrohydrodynamic Micropumps
Strong fit — clear ROI and a fast path to value.
End user65 fit
Thermal Bubble Micropumps
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Pump Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Fluid Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel28%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Pump Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Micropumps for Medical Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified21%
Evaluation12%
Closed-won8%
$12.5KCAC
$71KLTV
5.7:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Micropumps for Medical Market is a resilient opportunity — $7.80B by 2033, compounding at 5.3%.
TAM · 2025$5.18Btoday
TAM · 2033$7.80Bforecast
CAGR5.3%2027–2033
Cumulative$57.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.80BTotal addressable market
SAM$3.03BServiceable available market
SOM$527MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.3% CAGR
Demand compounds through 2033, outpacing GDP across Pump Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Pump Technology moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.80BLarge & growingTAM by 2033 at 5.3% CAGR
$3.03BServiceable nowreachable with today’s model
$527MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.09BBear3.4% CAGR
$7.80BBase5.3% CAGR
$9.99BBull6.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Micropumps for Medical Market — a $9.61B market by 2033. Plan: grow share from 6.0% to 11.7%.
Market size · 2033$9.61Btotal addressable
Market CAGR10.8%2027–2033
Target share11.7%from 6.0% today
Revenue ambition$1.12Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.0% | 11.7% | On track |
| Revenue | $581M | $1.12B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.2% | 38.3% | On track |
| Customer retention | 87.5% | 96.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Pump Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Pump Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $139M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Pump Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Micropumps for Medical Market conversation — a $3.26B market you can size, segment and defend in minutes.
Market size · 2033$3.26Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,732+accounts in scope
Typical ROI5.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Pump Technology
Goal Grow share in Pump Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.8×return on cost, year one
< 3 mopayback period
$95K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Tecan Group Ltd.Harvard Apparatus (Harvard BioscienceInc.)Bartels Mikrotechnik GmbHDolomite Microfluidics (a division of Blacktrace Holdings Ltd.)Micrel Medical DevicesNResearch Inc.Debiotech SA+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Micropumps for Medical Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Micropumps for Medical Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Microprocessor Ventilatior Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMicroprocessor Prosthetic Foot Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportMicroprocessor Knee Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportMicroprocessor Controlled Laboratory Sterilizer Market
Market size, share, segmentation and regional forecast.
$378M market · 2025 base year
View reportMicro Powder Silymarin Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportMicropositioner Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportMicroporous Surgical Tape Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportMicroporous Surgical Paper Tape Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMicroporous Polysaccharide Hemospheres (MPH) Market
Market size, share, segmentation and regional forecast.
$777M market · 2025 base year
View reportMicroporous Plate Reader Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportMicroporous Hollow Fiber Oxygenator Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportMicroplate Washing Machine Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.